<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Pricing | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta
    name="description"
    content="Pricing and access information for LiquidMammo™, a microRNA-based supplemental breast cancer screening test currently under CLIA LDT development."
  />

  <!-- Styles -->
  assets/css/styles.css

  <!-- Favicon -->
  favicon.png
</head>

<body>

<header class="container">
  <nav>index.html← Home</a></nav>
</header>

<main class="container">

  <h1>Pricing &amp; Access</h1>

  <section class="section-tight">
    <p>
      LiquidMammo™ is currently in validation and early‑access rollout. During this period, we offer a
      simplified and transparent pricing model for both patients and clinicians. Final pricing may evolve
      as clinical performance is established and reimbursement pathways expand.
    </p>

    <p class="notice" style="margin-top:14px;">
      LiquidMammo is being developed as a <strong>CLIA Laboratory Developed Test (LDT)</strong>.
      It is not yet FDA‑cleared/approved.
    </p>
  </section>

  <!-- Pricing structure -->
  <section class="panel-light section-tight">
    <h2>Pricing structure</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(280px,1fr));margin-top:18px;">

      <div class="card">
        <h3>Self‑pay (Early Access)</h3>
        <p class="price" style="margin:6px 0 12px 0;">$295</p>
        <p class="small">
          Early‑access pricing for patients whose clinicians participate in the validation program.
          Includes blood draw processing, microRNA analysis, and clinician‑ready report.
        </p>
      </div>

      <div class="card">
        <h3>Clinician partner program</h3>
        <p class="price" style="margin:6px 0 12px 0;">$0–$195</p>
        <p class="small">
          Discounted rates for practices enrolling in validation collaborations (limited availability).
          Includes training kits, clinical support materials, and dedicated onboarding.
        </p>
      </div>

      <div class="card">
        <h3>Future insurance coverage</h3>
        <p class="small">
          Insurance and reimbursement pathways are in development. Coverage will depend on clinical
          validation, payer policy, and medical‑necessity documentation.
        </p>
      </div>

    </div>
  </section>

  <!-- What is included -->
  <section class="section-tight">
    <h2>What your price includes</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));margin-top:20px;">
      <div class="card-mini">
        <h4>microRNA profiling</h4>
        <p class="small">High‑sensitivity multi‑marker molecular analysis performed in a CLIA lab.</p>
      </div>
      <div class="card-mini">
        <h4>Sample processing</h4>
        <p class="small">Plasma stabilization, quality control, and extraction included.</p>
      </div>
      <div class="card-mini">
        <h4>Clinical report</h4>
        <p class="small">A structured clinician‑ready interpretation with guidance for follow‑up.</p>
      </div>
      <div class="card-mini">
        <h4>Support</h4>
        <p class="small">Optional onboarding for clinicians; direct helpdesk for early‑access patients.</p>
      </div>
    </div>
  </section>

  <!-- When LiquidMammo is useful -->
  <section class="panel-light section-tight">
    <h2>Who should consider the test?</h2>

    <ul class="list-tight">
      <li>Patients with <strong>dense breasts</strong> (BI‑RADS C/D).</li>
      <li>Patients seeking a <strong>non‑invasive supplemental tool</strong> to increase screening confidence.</li>
      <li>Patients with <strong>family history</strong> or elevated risk profiles.</li>
      <li>Women under 40 with <strong>risk indicators</strong> but not yet eligible for routine mammograms.</li>
      <li>Clinics serving <strong>under‑screened populations</strong> or patients avoiding mammography discomfort.</li>
    </ul>
  </section>

  <!-- Enrollment CTA -->
  <section class="section">
    <h2>Get started</h2>

    <div style="margin-top:16px;display:flex;gap:12px;flex-wrap:wrap;">
      patients.html#patientsLearn More as a Patient</a>
      clinicians.html#enrollClinician Enrollment</a>
      contact.html#pricingQuestions?</a>
    </div>
  </section>

</main>

<footer>
  <div class="container footer-grid">
    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral,
        Cambridge, MA (MIT innovation ecosystem).
      </p>
    </div>
    <div class="footer-logo" style="justify-content:flex-end;text-align:right">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">Developed by<br/>MultiOmics Inc.</div>
    </div>
  </div>

  <div class="container footer-note">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    privacy.htmlPrivacy &amp; Compliance</a> •
    contact.htmlContact</a>
  </div>
</footer>

</body>
</html>

